LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹11 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 25.99 | |
| Mar2024 | ₹15 Cr | -60.08 | |
| Mar2023 | ₹38 Cr | 245.81 | |
| Mar2022 | ₹11 Cr | -57.89 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Non-Current Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹974.7 Cr | -0.6% | 1.2% | -42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.6% |
1.2% |
-42.4% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses